← All companies
BBIO annual revenue
BridgeBio Pharma, Inc.
BBIO - CIK 0001743881
Market cap$13.20 B
Rank#791
SEC filings777
BridgeBio Pharma, Inc. revenue by year
BridgeBio Pharma, Inc. (BBIO) reported revenue of $502.08M for fiscal year 2025, as filed in its audited annual report with the SEC.
BBIO revenue 2019-2025
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $502.08M | +126.3% |
| FY 2024 | $221.90M | +2285.3% |
| FY 2023 | $9.30M | -88.0% |
| FY 2022 | $77.65M | +11.4% |
| FY 2021 | $69.72M | +745.1% |
| FY 2020 | $8.25M | -79.7% |
| FY 2019 | $40.56M | - |
Revenue of similar companies
Frequently asked questions
How much revenue does BridgeBio Pharma, Inc. make?
BridgeBio Pharma, Inc. (BBIO) reported revenue of $502.08M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has BridgeBio Pharma, Inc.'s revenue changed over time?
Between fiscal 2019 and fiscal 2025, BridgeBio Pharma, Inc.'s revenue grew from $40.56M to $502.08M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.